𝔖 Bobbio Scriptorium
✦   LIBER   ✦

765 Association Between Compliance and Clinical Recurrence in Patients With Quiescent Ulcerative Colitis Receiving MMX® Mesalamine 2.4g/Day as Maintenance Therapy: Results of the Phase IV Simple Trial

✍ Scribed by Sunanda V. Kane; Dory M. Solomon; Mary Palmen; Karen Barrett


Book ID
119431336
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
80 KB
Volume
138
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.